|
HS Code |
786308 |
| Chemical Name | 7-Bromoquinoline-2-carboxylic acid |
| Cas Number | 91419-52-8 |
| Molecular Formula | C10H6BrNO2 |
| Molecular Weight | 252.07 g/mol |
| Appearance | White to beige solid |
| Melting Point | 238-240°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Purity | Typically ≥98% |
| Smiles | C1=CC2=NC(=CC=C2C(=O)O)C=C1Br |
| Inchi | InChI=1S/C10H6BrNO2/c11-7-3-1-2-6-8(7)12-5-4-9(6)10(13)14/h1-5H,(H,13,14) |
| Storage Temperature | Room temperature |
| Synonyms | 2-Quinolinecarboxylic acid, 7-bromo- |
As an accredited 7-Bromoquinoline-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 7-Bromoquinoline-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
7-Bromoquinoline-2-carboxylic acid might not turn heads in everyday conversation, but among researchers and creators on the frontiers of chemical science, this compound has earned a spot in the spotlight. Its chemical formula, C10H6BrNO2, tells some of the story, signaling a structure that includes both aromatic stability and targeted reactivity. Rough translation: it plays well in a lab setting and occupies a unique niche where bromine chemistry meets nitrogen-containing aromatic systems. Studies in recent years have shown remarkable interest in derivatives of quinoline, especially as routes to efficient syntheses, medicinal chemistry, and material sciences open up—so this compound's role keeps growing.
Think of quinoline as a trusty bicycle, with functional groups as gears that shift its behavior from coasting to climbing mountains. Swapping out positions on its ring with carboxyl or bromo groups changes its course entirely. Here, introducing bromine at the seventh position forms a gateway for chemists to introduce all sorts of new functionalities down the line. The carboxyl group on the second position opens doors for coupling reactions, esterifications, and salt formations. With these two groups in play, synthetic pathways expand rapidly. More options on the benchtop usually mean greater possibilities, especially in complex multi-step syntheses where selectivity and stability matter a lot.
Most hands-on chemists gravitate toward compounds that offer predictable results. From my own work and discussions with colleagues, selectivity matters as much as reactivity. In the lab, 7-bromoquinoline-2-carboxylic acid shows strong reliability in Suzuki-Miyaura cross-coupling and Buchwald-Hartwig aminations. Its bromo group activates nicely under palladium catalysis, making arylation routes straightforward. The carboxylic acid moiety enables downstream transformations; amidation and ester exchange reactions run smooth, even under mild conditions.
Experimental yields often benefit from the stability of quinoline’s aromatic core. There’s less risk of decomposing under the slightly harsher conditions sometimes used in halogen-metal exchange or Cu-catalyzed N-arylation. From my observation, this type of predictability is vital when handling ambitious synthesis projects that require careful planning and substantial investment of time. Sloppy intermediates cost more in the end, regardless of the starting material’s price. Research groups prize compounds like this one for lowering the overall uncertainty in a complicated experimental sequence.
Looking at a typical catalog of heterocyclic building blocks, many feature either unfunctionalized quinolines or halogenated benzenes. Both classes serve important purposes, but 7-bromoquinoline-2-carboxylic acid stands out in how smoothly it can bridge the gap between aromatic substitution and targeted molecular elaboration. Compare it to unsubstituted quinoline: the starting material lacks clear points of modification, which means extra steps just to get a functional handle. That’s time, reagents, and money. Substituted benzenes might offer a similar functional motif, yet they’re missing the nitrogen. This difference means altered electronic properties and often slower or less selective reactivity.
In contrast, other bromoquinoline isomers, such as substitutions on the 5- or 8-position, deliver different challenges in downstream chemistry. The carboxylic acid on the two-position brings a strategic advantage—it pairs well with well-established coupling chemistries. For those mapping out a synthesis strategy, this flexibility saves planning time and lowers the risk of dead-ends. In a pharmaceutical context, the distinction between a successful scale-up and a month-long troubleshooting session can hinge on a single functional group’s location. Many medicinal chemists admit quietly that having an acid group just two carbons away from a nitrogen atom offers routes to all sorts of ring closures, amide transformations, or even unique salt-forming abilities that benefit formulation work.
Chasing new molecules takes creativity—having a compound like 7-bromoquinoline-2-carboxylic acid in the toolkit makes the journey smoother. In drug discovery, researchers often rely on “privileged scaffolds”—structures proven useful as backbones for bioactive agents. Quinoline rings keep showing up in kinase inhibitors, antimalarial agents, and antibacterial compounds. Adding a carboxyl and bromo group makes this basic scaffold even more versatile for tuning selectivity or improving metabolic stability.
Fine chemical production teams have also leaned on this molecule, especially when looking for high-purity intermediates. Its crystalline nature and commercial availability often mean lower downstream purification costs. Compared to certain other building blocks, which show sensitivity to oxygen or ambient moisture, this compound remains stable under ambient storage. That reduces wastage and makes for easier inventory management. In my experience, that points to a lower risk of batch-to-batch variability—an underappreciated advantage when hundreds of grams or even kilos are on the line. Keeping the process reliable directly supports quality assurance at every stage.
No serious chemical commentary skips over responsible handling. Working with halogenated aromatics poses its own hazards. Bromo compounds can irritate skin and mucosa, and dust from fine powders can present respiratory risks. Lab procedures always demand gloves and fume hoods, not just because of regulations but because everyone wants to finish the day healthy. Some carboxylic acids carry corrosive risk, though 7-bromoquinoline-2-carboxylic acid is less aggressive than strong mineral acids. Reports from chemical safety offices stress that adequate ventilation, eye protection, and routine maintenance of containment equipment prevent oversights from becoming injuries. I’ve found that a quick review of storage conditions—cool, dry, and segregated from incompatibles—goes a long way. Group safety culture depends on everyone knowing not just the glowing potential of the molecule, but its less glamorous side effects, too.
Those working in applied chemistry often debate how much purity is “enough.” In practice, even minor impurities wreck catalyzed reactions or complicate chiral syntheses. Suppliers typically offer this acid at 97% and above. That threshold serves most organic synthesis and development work. Impurities like residual halides, toluenes, or quinoline side products add headaches; every unexpected side reaction or split peak on an NMR spectrum represents wasted time. High-purity batches mean spectral analysis matches expectations, yields stay predictable, and post-synthesis cleanup doesn’t become a project of its own. I’ve watched junior chemists learn the tough way that shaving a couple of dollars off the starting material tag often ends up costing multiples more in lost product and troubleshooting reagents. For startups needing reliability, the up-front investment pays for itself by preventing schedule-killing surprises.
Several decades back, custom synthesis ruled the landscape for non-standard brominated quinolines. Lead times stretched into months, minimum order sizes meant tight budgets, and quality varied widely. Access improved by leaps over the past fifteen years. Now, large-scale manufacturers keep this kind of intermediate in regular production. That means academic labs and commercial partners alike can secure reasonable amounts—gram through kilogram scale—without costly delays. In some industrial practice, convenient access alone tips the balance in favor of a particular route. Having a robust supply chain supports strategic planning and limits interruptions. Academic investigators benefit too; instead of burning time on problematic intermediate synthesis, research efforts can shift toward real innovation.
Growing concerns about chemical waste put all halogenated heterocycles under a microscope. Bromine generally triggers more regulatory interest than lighter halogens; its persistent nature in ecosystems means careful oversight during disposal. The relatively small scale of 7-bromoquinoline-2-carboxylic acid use, compared to mass-market chemicals, limits its direct impact. Still, waste minimization and green chemistry protocols push for more atom-efficient transformations. Newer research aims to substitute harsh halogenation reagents with milder or even photochemical methods—leading to safer processes with smaller environmental footprints. Some teams recycle reaction solvents and find lower-temperature conditions for coupling reactions. These shifts may seem incremental, but aggregated across many labs, they shrink the overall burden without sacrificing yield or reproducibility. Responsible sourcing, informed reagent choices, and improved waste stream management all contribute to a genuinely sustainable approach.
Sifting through literature and product catalogs leaves out a lot of what those at the bench know. Heating scares, vacuum pump failures, and clogs in reaction vessels stem from poorly understood behavior or from impurities in the sample stocks. In my experience, the 7-bromoquinoline-2-carboxylic acid stands up well, handling moderate heat and a variety of common solvent systems. Unlike some bromoaromatics, there’s less risk of side reactions with standard glassware, and the product’s slight solubility in polar aprotic solvents keeps workups manageable. TLC monitoring and standard NMR protocols both perform reliably, which cuts down on endless repetitions—valuable for any researcher facing grant deadlines. Real-world reliability breeds confidence in choosing this intermediate for increasingly complex modular syntheses.
Taken together, the differences between this molecule and competing building blocks aren’t just academic. Placement of the bromo and carboxylic acid groups on the quinoline ring gives unique reactivity—notably more predictable than benzoic acid derivatives or plain quinolines. More than a few researchers have reported that reaction monitoring by HPLC or GC comes easy, traceable by both UV and MS. This utility translates into lower troubleshooting loads, easier validation of product identity, and reduced analytical guesswork. From structure-building in lead generation projects to bespoke material science syntheses, a single compound capable of straightforward downstream modification remains in high demand.
Preference for this intermediate links back to its track record. Journal articles on cross-coupling or amide bond formation often cite this compound for one reason: the results hold up, letting research move forward without unexpected breakdowns or side products more stubborn than intended. Working chemists don’t want magic—they want dependability paired with adaptability. From preparation of new ligands in photochemistry studies to small-molecule screen libraries in therapeutic research, success often depends on having access to intermediates that won’t sabotage the end goals.
Addressing recurring challenges in research and production means building on what works while staying honest about limitations. For supply risk, forming long-term partnerships with reliable suppliers builds resilience into procurement. Establishing backup sources and even occasional in-house synthesis guarantees uninterrupted workflow, especially through global supply chain shocks like those seen in recent years. Lab teams benefit from updating and documenting their handling protocols, crossing off sources of human error and ensuring that valuable intermediates like this don’t disappear down the drain or vanish through accidental spills. Ongoing education in chemical hygiene—ventilation, separation, and waste handling—builds group confidence and safety habits that endure even when faces in the group change.
From an environmental perspective, choosing greener reagents and increasing reliance on milder conditions softens resource use and waste output. Taking into account end-of-life disposal from the outset helps avoid costly remediation efforts later. Collaborative research—open data sharing on synthesis conditions, side products, and even unexpected failures—lets the field as a whole move past repeating avoidable mistakes.
For those working in regulated industries, engaging upstream with regulatory and environmental officers means fewer surprises as processes scale. The key—one reinforced by hard-earned experience—is to invest in clear planning, prioritize safety, and stay open to new technologies or workflows. These habits ensure that 7-bromoquinoline-2-carboxylic acid continues enabling efficient, innovative, and responsible research across industries.
Whether preparing for a day in the lab or scoping out a new synthetic strategy, practical needs go beyond simple product lists and catalog numbers. A building block like 7-bromoquinoline-2-carboxylic acid stands out because it offers adaptability, reliability, and a proven record across multiple fields. Its unique positioning on the quinoline backbone makes it a useful springboard for further modifications, whether in experimental drug development or materials science. The users who benefit most are those ready to marry hands-on savvy with strategic planning—leaning on robust intermediates to brave new frontiers in chemistry with confidence and safety. In the end, that balance between capability, safety, and creativity defines the true value of this compound in the modern lab.